​Salesforce, Inc. (NYSE:CRM) is one of the Best Quality Stocks to Buy Before 2026. On December 17, Salesforce, Inc. (NYSE:CRM) announced that Novartis (NYSE:NVS) has selected the company’s Agentforce Life Sciences for Customer Engagement to connect patients and Healthcare professional experiences. ​Novartis has already invested in the company through Agentforce Health, 360 for Health & Life Sciences, MuleSoft for Life Sciences, and Agentforce Marketing. Now it plans to unify the engagement across marketin ...

公司近期财务表现与业绩指引 - 公司2025财年第三季度营收达到103亿美元，同比增长9%，按固定汇率计算增长8% [2] - 第三季度净利润为20.86亿美元，较上年同期的15.27亿美元显著增长 [3] - 公司上调了2026财年营收指引至414.5亿美元至415.5亿美元 [3] - 第三季度当期剩余履约义务达到294亿美元，同比增长11%，预示未来收入渠道强劲 [3] 业务增长驱动因素 - 订阅与支持收入在截至2025年10月31日的三个月和九个月内实现增长，主要驱动力是来自新客户、现有客户升级和增购的量增 [2] - Agentforce和Data 360产品是公司增长的主要动力 [3] 机构观点与市场定位 - 摩根士丹利将公司股票目标价从405美元下调至398美元，但维持“超配”评级 [1] - 此次目标价调整发生在公司发布强劲财报后，摩根士丹利在其软件覆盖范围内调整了预测和估值 [1] - 公司被列为对冲基金看好的顶级人工智能和技术股之一 [1] 公司主营业务 - 公司提供客户关系管理技术，旨在连接企业与客户 [4]

Salesforce, Inc. (NYSE:CRM) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 25, Salesforce, Inc. (NYSE:CRM) announced the launch of MuleSoft Agent Fabric to solve the problem of AI fragmentation. Management noted that as companies rapidly adopt AI, it has resulted in agent sprawl, which creates disconnected workflows, duplicate automations, and security gaps. This leads to chaos instead of productivity. MuleSoft Agent Fabric acts like an air traffic controller, connecting and coord ...